findmyKOL

Jessica Allegretti, MD

Enriched profile

Medical Director, Crohn's and Colitis Center, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School · Brigham and Women's Hospital

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyGastroenterologyFocusIBD (Crohn's / UC)
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding2018–2026Why? →

Jessica Allegretti is Medical Director, Crohn's and Colitis Center, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital. ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Jessica R. Allegretti, MD, is Medical Director, Crohn's and Colitis Center, Brigham and Women's Hospital. The public record shows 318 publications with 7,522 citations (h-index 44), centered on IBD (Crohn's / UC). It also documents an investigator role on 8 registered clinical trials, industry payments reported by 22 companies, 4 NIH-funded awards (2018–2026).

  • Top research focus: IBD (Crohn's / UC)
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
IBD (Crohn's / UC)7 trialsColitis, Ulcerative2 trialsUlcer2 trialsColitis2 trialsCrohn Disease2 trialsObesity1 trialClostridium Infections1 trial

Research focus

OpenAlex concept fingerprint
IBD (Crohn's / UC)

Drugs & molecules

across trials, industry payments and publications
Tremfyageneric · GuselkumabClinical trials—Industry payments84Publications—Stelarageneric · UstekinumabClinical trials—Industry payments74Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments27Publications—Rebyotageneric · Fecal microbiota, liveClinical trials—Industry payments26Publications—Skyrizigeneric · RisankizumabClinical trials—Industry payments17Publications—Velsipitygeneric · EtrasimodClinical trials—Industry payments15Publications—Zeposiageneric · OzanimodClinical trials—Industry payments13Publications—Inflectrageneric · InfliximabClinical trials—Industry payments12Publications—Xeljanzgeneric · TofacitinibClinical trials—Industry payments6Publications—Abriladageneric · AdalimumabClinical trials—Industry payments1Publications—Retacritgeneric · Epoetin alfaClinical trials—Industry payments1Publications—Vowstgeneric · Fecal microbiota spores, liveClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments129Janssen Biotech, Inc.Clinical trials—Industry payments111Pfizer Inc.Clinical trials—Industry payments31Ferring Pharmaceuticals Inc.Clinical trials—Industry payments30E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments28Janssen Scientific Affairs, LLCClinical trials—Industry payments19Celgene CorporationClinical trials—Industry payments12Merck Sharp & Dohme LLCClinical trials—Industry payments8Janssen Global Services, LLCClinical trials—Industry payments7Janssen Research & Development, LLCClinical trials—Industry payments7Brigham and Women's HospitalClinical trials5Industry payments—Celltrion USA Inc.Clinical trials—Industry payments5Genentech, Inc.Clinical trials—Industry payments4GlaxoSmithKline, LLC.Clinical trials—Industry payments3Medtronic, Inc.Clinical trials—Industry payments3Sebela Pharmaceuticals Inc.Clinical trials—Industry payments2Aimmune Therapeutics, Inc.Clinical trials—Industry payments1Boston Children's HospitalClinical trials1Industry payments—Eli Lilly and CompanyClinical trials—Industry payments1Ferring Pharmaceuticals ASClinical trials—Industry payments1Fresenius Kabi USA, LLCClinical trials—Industry payments1Kowa Company, Ltd.Clinical trials—Industry payments1Kowa Research Institute, Inc.Clinical trials—Industry payments1Lilly USA, LLCClinical trials—Industry payments1Scott B. Snapper, MD PHDClinical trials1Industry payments—University of North Carolina, Chapel HillClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
44h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 2018–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    45%
    Antidiarrheal10%
    Diphenoxylate-Atropine100%
    Part D<11 patients
    Proton pump inhibitor10%
    Pantoprazole Sodium100%
    Part D<11 patients

    + 4 more classes in this area

  • Cancer & immunology

    21.8%
    Interleukin-12 Antagonist17%
    Stelara100%
    Part D<11 patients
    Interleukin-23 Antagonist4.8%
    Skyrizi On-Body100%
    Part D<11 patients
  • Anti-infectives

    19.7%
    Glycopeptide Antibacterial19.7%
    Vancomycin Hcl100%
    Part D≥11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)53.8% facility · 46.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

4 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jessica-allegretti-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    allegrettilab.com/meet-dr-allegretti-1

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allegrettilab.com ↗
  • ResearchGate

    researchgate.net/profile/Jessica-Allegretti

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • ResearchGate

    researchgate.net/profile/Jessica-Allegretti-3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/DrAllegrettiIBD

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • X / Twitter

    x.com/DrJessicaA

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Other

    gi.org/2021/01/06/conversations-with-women-in-gi-jessica-a-allegretti-md-mph-facg

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →gi.org ↗
  • Other

    microbiome.mit.edu/microbiome_news/an-interview-with-dr-jessica-r-allegretti-md-mph

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →microbiome.mit.edu ↗
  • Other

    physiciandirectory.brighamandwomens.org/details/12662/jessica-allegretti-gastroenterology_hepatology_and_endoscopy-internal_medicine-boston

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
  • Other

    theguthealthpodcast.buzzsprout.com/2293918/episodes/15503107-diarrhea-from-c-diff-to-ibs-d-with-dr-jessica-allegretti

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theguthealthpodcast.buzzsprout.com ↗
  • YouTube

    m.youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →m.youtube.com ↗
  • X / Twitter

    X (Twitter) profile: @DrJessicaA

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    Internal Medicine/Gastroenterology, American Board of Internal Medicine

    2015
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
  • MD

    University of Miami (Miller School of Medicine)

    2009
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
  • MPH

    Harvard T.H. Chan School of Public Health (Clinical Effectiveness, clinical trials focus)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allegrettilab.com ↗

Editorial & leadership roles

journal and society appointments
  • Founder and Director

    Fecal Microbiota Transplantation Program, Brigham and Women's Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →allegrettilab.com ↗
  • Clinical Development Lead

    Massachusetts-Host Microbiome Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →allegrettilab.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.